PharmaCyte Biotech, Inc.

Q2 2024 13F Holders

Symbol
PMCB
CUSIP
71715X203
Type
Equity
Class
COM NEW
Num filings
31
Total reported value, excl. options
$2.02 M
Manager Report Date Value ($000) Shares Option Type